Transcription Factor Screening for P. falciparum Therapy
David Segal of the University of California, Davis in the U.S. will develop a high-throughput screen to search for artificial transcription factors (ATF) that are candidates to treat P. falciparum infections. ATFs could be a gene-regulating drug resource for the study and treatment of malaria.